S J Parker1, P E Watkins. 1. Biomedical Sciences, Defence Evaluation and Research Agency, Porton Down, Salisbury SP4 OJQ, UK.
Abstract
BACKGROUND: The mortality rate from sepsis has improved little over the past two decades. One reason for this has been the use of flawed or inappropriate experimental models in preclinical sepsis studies. METHODS: A literature review of animal models of sepsis was performed following a Medline search based on the following medical subject headings: disease models, endotoxin, inflammation, peritonitis and sepsis. Additional references were identified from the papers identified in the search. RESULTS AND CONCLUSION: Many animal models of sepsis have been described but none has proved to be superior. Extrapolation of results from endotoxicosis or bacterial infusion models should be regarded with caution. Peritonitis models should be accepted as the 'gold standard' but the use of appropriate virulent bacterial species needs to be ensured. A standardized panel of animal models for the preclinical assessment of immunomodulatory agents should be established, including at least one immuno- suppressed model to simulate the immunocompromised patient with sepsis. A uniform and valid definition of sepsis applicable to both small and large animal species is required.
BACKGROUND: The mortality rate from sepsis has improved little over the past two decades. One reason for this has been the use of flawed or inappropriate experimental models in preclinical sepsis studies. METHODS: A literature review of animal models of sepsis was performed following a Medline search based on the following medical subject headings: disease models, endotoxin, inflammation, peritonitis and sepsis. Additional references were identified from the papers identified in the search. RESULTS AND CONCLUSION: Many animal models of sepsis have been described but none has proved to be superior. Extrapolation of results from endotoxicosis or bacterial infusion models should be regarded with caution. Peritonitis models should be accepted as the 'gold standard' but the use of appropriate virulent bacterial species needs to be ensured. A standardized panel of animal models for the preclinical assessment of immunomodulatory agents should be established, including at least one immuno- suppressed model to simulate the immunocompromised patient with sepsis. A uniform and valid definition of sepsis applicable to both small and large animal species is required.
Authors: Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An Journal: Immunopharmacol Immunotoxicol Date: 2010-06 Impact factor: 2.730
Authors: Gary Nieman; David Brown; Joydeep Sarkar; Brian Kubiak; Cordelia Ziraldo; Joyeeta Dutta-Moscato; Christopher Vieau; Derek Barclay; Louis Gatto; Kristopher Maier; Gregory Constantine; Timothy R Billiar; Ruben Zamora; Qi Mi; Steve Chang; Yoram Vodovotz Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598